CytomX Therapeutics, Inc. (CTMX)
5.335
-0.10
(-1.75%)
USD |
NASDAQ |
Feb 13, 16:00
5.335
0.00 (0.00%)
After-Hours: 17:29
CytomX Therapeutics Free Cash Flow : -72.35M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| REGENXBIO, Inc. | -106.28M |
| ACADIA Pharmaceuticals, Inc. | 98.97M |
| Alnylam Pharmaceuticals, Inc. | 221.36M |
| Savara, Inc. | -99.27M |
| BioMarin Pharmaceutical, Inc. | 825.79M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -15.55M |
| Cash from Investing (Quarterly) | 0.439M |
| Cash from Financing (Quarterly) | 0.253M |
| Free Cash Flow Per Share (Quarterly) | -0.0935 |
| Free Cash Flow to Equity (Quarterly) | -14.13M |
| Free Cash Flow to Firm (Quarterly) | -15.42M |
| Free Cash Flow Yield | -11.76% |